Financial Eye – Medtronic (NYSE:) (NYSE: MDT) reported second quarter EPS of $1.30, $0.02 better than the analyst estimate of $1.28. Revenue for the quarter came in at $7.6B versus the consensus estimate of $7.7B.
Medtronic’s stock price closed at $82.29. It is down -10.69% in the last 3 months and down -27.42% in the last 12 months.
Medtronic saw positive EPS revisions and negative EPS revisions in the last 90 days. See Medtronic’s stock price’s past reactions to earnings here.
According to InvestingPro, Medtronic’s Financial Health score is “ performance“.
Check out Medtronic’s , and Medtronic’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Financial Eye’s earnings calendar